Comparison of the Efficacy of Rapid Tests to Identify COVID-19 Infection (CATCh COVID-19)

Status unconfirmed · Phase 1

Conditions studied: COVID-19

In brief

This study is designed to compare the efficacy of detection of COVID-19 infection using the serology test in blood sample and the PCR-based test in the nasopharyngeal (NP) and sputum sample. Furthermore, it aims to evaluate the temporal trend of appearance of IgM and IgG in blood.

Key facts

Study ID

NCT04372004

Run by

Texas Cardiac Arrhythmia Research Foundation

People needed

100

Starts

2020-05-08

Expected to finish

2021-06-01

Last updated by the study team

2020-08-11

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• • Male or female over 18 years of age at the time of enrollment
• Current symptoms of COVID-19 ; fever alone or fever and at least one of the following symptoms need to be present
• Dry cough
• Sore throat
• Shortness of breath
• Chills
• Muscle pain
• Headache
• New loss of taste or smell
• Chills with repeated shaking

You may not qualify if…

• • Unwilling to provide informed consent
• Unwilling to undergo bi-weekly serological test during the 1-month enrollment

Where it is running

• Texas Cardiac Arrhythmia Institute — Austin, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.